Disc Medicine IRON Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Vertex PharmaceuticalsVRTX

$1.98B+29.5%

Protagonist TherapeuticsPTGX

$9.22M-18.3%

Agios PharmaceuticalsAGIO

$31.17M-36.1%

Beam TherapeuticsBEAM

$250.82M+58.6%

BridgeBio PharmaBBIO

$3.26B+32,101%

FAQ

What is Disc Medicine's total debt?

Disc Medicine (IRON) reported total debt of $31.06M in Q1 2026.

How has Disc Medicine's total debt changed year-over-year?

Disc Medicine's total debt increased by 1.4% year-over-year, from $30.64M to $31.06M.

What is the long-term trend for Disc Medicine's total debt?

Over 5 years (2020 to 2025), Disc Medicine's total debt has grown at a 21.3% compound annual growth rate (CAGR), from $11.69M to $30.68M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.